{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:34:17Z","timestamp":1791480857003,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Extended spectrum \u03b2-lactamases (ESBLs) are a group of beta-lactamase enzymes that confer resistance to the oxyimino-cephalosporins and monobactams. The emergence of ESBL - producing genes possesses a serious threat for treating infections since it is associated with multi-drug resistance. This study was focused to identify the ESBLs producing genes from\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      isolates from clinical samples from a referral-level tertiary care hospital in Lalitpur.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a cross-sectional study conducted from September 2018 to April 2020 at the Microbiology Laboratory of Nepal Mediciti Hospital. Clinical samples were processed, and culture isolates were identified and characterized following standard microbiological techniques. An antibiotic susceptibility test was performed by a modified Kirby-Bauer disc diffusion method as recommended by Clinical and Laboratory Standard Institute guidelines.Extended -spectrum beta-lactamases were phenotypically confirmed by the combined disc method. The ESBL-producing genes\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>TEM<\/jats:sub>\n                      ,\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX\u2212M<\/jats:sub>\n                      and\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>SHV<\/jats:sub>\n                      were confirmed by PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 1449 total\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates, 22.29% (323\/1449) isolates were multi-drug resistant (MDR). Among the total MDR\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates, 66.56% (215\/323) were ESBL producers. The maximum number of ESBL\n                      <jats:italic>E. coli<\/jats:italic>\n                      was isolated from urine 90.23% (194) followed by sputum 5.58% (12), swab 2.32% (5), pus 0.93% (2), and blood 0.93% (2). The antibiotic susceptibility pattern of ESBL\n                      <jats:italic>E. coli<\/jats:italic>\n                      producers showed the highest sensitivity toward tigecycline (100%) followed by polymyxin b, colistin and meropenem. Out of 215 phenotypically confirmed ESBL\n                      <jats:italic>E. coli<\/jats:italic>\n                      , only 86.51% (186) isolates were found to be positive by PCR for either\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>TEM<\/jats:sub>\n                      or\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX\u2212M<\/jats:sub>\n                      genes. Among the ESBL genotypes, the most common were\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>TEM<\/jats:sub>\n                      63.4% (118) followed by\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX\u2212M<\/jats:sub>\n                      36.6% (68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The emergence of MDR and ESBL \u2013 producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates with high antibiotic \u2013 resistant rates to commonly used antibiotics and increased predominance of major gene types\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>TEM<\/jats:sub>\n                      is a serious concern to the clinicians and microbiologists. Periodic monitoring of antibiotic susceptibility and associated genes would help guide the rationale use of antibiotics for treating the predominant pathogen\n                      <jats:italic>E. coli<\/jats:italic>\n                      in the hospitals and healthcare facilities of the communities.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-023-00584-0","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:02:51Z","timestamp":1683280971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Molecular detection of plasmid mediated blaTEM, blaCTX\u2212M,and blaSHV genes in Extended Spectrum \u03b2-Lactamase (ESBL) Escherichia coli from clinical samples"],"prefix":"10.1186","volume":"22","author":[{"given":"Mahesh Kumar","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha Raj","family":"Banjara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"issue":"1","key":"584_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21775\/cimb.017.011","volume":"17","author":"S Ghafourian","year":"2015","unstructured":"Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta- lactamases: definition, classification and Epidemiology.Curr. Issues Mol Biol. 2015;17(1):11\u201322. https:\/\/doi.org\/10.21775\/cimb.017.011.","journal-title":"Issues Mol Biol"},{"issue":"2","key":"584_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0255-0857(21)02884-X","volume":"22","author":"U Chaudhary","year":"2004","unstructured":"Chaudhary U, Aggarwal R. Extended spectrum \u03b2-lactamases (ESBL): emerging threat to clinical therapeutics. Indian J Med Microbiol. 2004;22(2):7. https:\/\/doi.org\/10.1016\/S0255-0857(21)02884-X.","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"584_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","volume":"22","author":"S Shaikh","year":"2015","unstructured":"Shaikh S, Fatima J, Shakil S, Mohd S, Rizvi D, Mohammad AK. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90\u2013101. https:\/\/doi.org\/10.1016\/j.sjbs.2014.08.002.","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"584_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/mdr.2011.0059","volume":"17","author":"M Perilli","year":"2011","unstructured":"Perilli M, Segatore B, Mugnaioli C, Celenza G, Rossolini GM, Stefani S, Luzzaro F, Pini B, Amicosante G. Persistence of TEM-52\/TEM-92 and SHV-12 extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Italy. Microb Drug Resist. 2011;17(4):521\u20134. https:\/\/doi.org\/10.1089\/mdr.2011.0059.","journal-title":"Microb Drug Resist"},{"key":"584_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1756-0500-2-49","volume":"2","author":"SE Mshana","year":"2009","unstructured":"Mshana SE, Kamugisha E, Mirambo M, Chakraborty T, Lyamuya EF. Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza,Tanzania. BMC Res Notes. 2009;2:49. https:\/\/doi.org\/10.1186\/1756-0500-2-49.","journal-title":"BMC Res Notes"},{"key":"584_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.7860\/JCDR\/2013\/5081.2872","volume":"7","author":"M Kaur","year":"2013","unstructured":"Kaur M, Aggarwal A. Occurrence of the CTX-M, SHV and the TEM genes among the Extended Spectrum Beta-Lactamase Producing Isolates of Enterobacteriaceae in a Tertiary Care Hospital of North India. J Clin Diagn Res. 2013;7:642\u20135. https:\/\/doi.org\/10.7860\/JCDR\/2013\/5081.2872.","journal-title":"J Clin Diagn Res"},{"key":"584_CR7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 32nded.CLSI supplement M100.Clinical and Laboratory Standards Institute,USA,2022."},{"key":"584_CR8","doi-asserted-by":"publisher","unstructured":"Rawat D, Nair D. Extended-spectrum \u03b2-lactamases in gram negative bacteria. J Glob Infect Dis.2010; 2(3): 263\u201374. https:\/\/doi.org\/10.4103\/0974-777X.68531.","DOI":"10.4103\/0974-777X.68531"},{"key":"584_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3126\/tujm.v6i0.26575","volume":"6","author":"N Guragain","year":"2019","unstructured":"Guragain N, Pradhan A, Dhungel B, Banjara MR, Rijal KR, Ghimire P. Extended spectrum beta-lactamase producing gram negative bacterial isolates from urine of patients visiting Everest Hospital, Kathmandu, Nepal. Tribhuvan Univ J Microbiol. 2019;6:26\u201331. https:\/\/doi.org\/10.3126\/tujm.v6i0.26575.","journal-title":"Tribhuvan Univ J Microbiol"},{"issue":"1","key":"584_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3126\/nmcj.v24i1.44145","volume":"24","author":"LK Khanal","year":"2022","unstructured":"Khanal LK, Amatya R, Sah AK, Adhikari RP, Khadka S, Sapkota J, Rai SK. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp. from urinary specimen in a tertiary care hospital. Nepal Med Coll J. 2022;24(1):75\u201380. https:\/\/doi.org\/10.3126\/nmcj.v24i1.44145.","journal-title":"Nepal Med Coll J"},{"key":"584_CR11","doi-asserted-by":"publisher","first-page":"5070742","DOI":"10.1155\/2018\/5070742","volume":"7","author":"G Fanta","year":"2018","unstructured":"Fanta G, Eshetu M, Mekidim M, Gemechu Z. Antimicrobial resistance profile of different clinical isolates against third-generation cephalosporins. J Pharm. 2018;7:5070742. https:\/\/doi.org\/10.1155\/2018\/5070742.","journal-title":"J Pharm"},{"issue":"3","key":"584_CR12","doi-asserted-by":"publisher","first-page":"e0000206","DOI":"10.1371\/journal.pgph.0000206","volume":"2","author":"SL Mitman","year":"2022","unstructured":"Mitman SL, Amato HK, Saraiva-Garcia C, Loayza F, Salinas L, Kurowski K, et al. Risk factors for third-generation cephalosporin-resistant and extended-spectrum \u03b2- lactamase-producing Escherichia coli carriage in domestic animals of semirural parishes east of Quito,Ecuador. PLOS Glob Public Health. 2022;2(3):e0000206. https:\/\/doi.org\/10.1371\/journal.pgph.0000206.","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"584_CR13","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.17554\/j.issn.2224-3992.2018.07.788","volume":"7","author":"MA Salem","year":"2018","unstructured":"Salem MA, Ahmed FA. Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among patients attending at Bushra Medical Laboratory, Tripoli, Libya. J Gastroenterol Hepatol Res. 2018;7(4):2671\u20135. http:\/\/www.ghrnet.org\/index.php\/joghr\/article\/view\/2380.","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"10","key":"584_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/23350","volume":"13","author":"S Subedi","year":"2016","unstructured":"Subedi S, Chaudhary M, Shrestha B, High. MDR AND ESBL producing Escherichia coli and Klebsiella pneumoniae from urine, Pus and Sputum samples. Br J Med &Medical Res. 2016;13(10):1\u201310. https:\/\/doi.org\/10.9734\/BJMMR\/2016\/23350.","journal-title":"Br J Med &Medical Res"},{"issue":"1","key":"584_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3126\/njb.v5i1.18868","volume":"5","author":"U Rimal","year":"2017","unstructured":"Rimal U, Thapa S, Maharjan R. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella species from urinary specimens of children attending Friendship International Children\u2019s hospital. Nepal J Biotechnol. 2017;5(1):32\u20138. https:\/\/doi.org\/10.3126\/njb.v5i1.18868.","journal-title":"Nepal J Biotechnol"},{"issue":"3","key":"584_CR16","doi-asserted-by":"publisher","first-page":"e103740","DOI":"10.5812\/iji.103740","volume":"7","author":"IA Naqid","year":"2020","unstructured":"Naqid IA, Balatay AA, Hussein NR, Saeed KA, Ahmed HA, et al. Antibiotic susceptibility pattern of Escherichia coli isolated from various clinical samples in Duhok City, Kurdistan Region of Iraq. Int J Infect. 2020;7(3):e103740. https:\/\/doi.org\/10.5812\/iji.103740.","journal-title":"Int J Infect"},{"issue":"1","key":"584_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41182-021-00313-3","volume":"49","author":"A Shilpakar","year":"2021","unstructured":"Shilpakar A, Ansari M, Rai KR, Rai G, Rai SK. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. Trop Med Health. 2021;49(1):23. https:\/\/doi.org\/10.1186\/s41182-021-00313-3.","journal-title":"Trop Med Health"},{"key":"584_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2576-389x.1000116","volume":"2","author":"K Yadav","year":"2017","unstructured":"Yadav K, Prakash S. Screening of ESBL producing Multidrug resistant E.coli from urinary tract infection suspected cases in Southern Terai of Nepal. J Infect Dis Diagn. 2017;2:2. https:\/\/doi.org\/10.4172\/2576-389x.1000116.","journal-title":"J Infect Dis Diagn"},{"issue":"4","key":"584_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/tropicalmed5040176","volume":"5","author":"PZ Kubone","year":"2020","unstructured":"Kubone PZ, Mlisana KP, Govinden U, Abia ALK, Essack SY. Antibiotic susceptibility and molecular characterization of uropathogenic Escherichia coli associated with community-acquired urinary tract infections in urban and rural settings in South Africa. Trop Med Infect Disease. 2020;5(4):176. https:\/\/doi.org\/10.3390\/tropicalmed5040176.","journal-title":"Trop Med Infect Disease"},{"key":"584_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijid.2018.12.017","volume":"80","author":"A Iftekhar","year":"2019","unstructured":"Iftekhar A, Md.Bodiuzzaman R, Sakina S. Antibiotic resistance in Bangladesh: Asystematic review. Int J Infect Dis. 2019;80:54\u201361. https:\/\/doi.org\/10.1016\/j.ijid.2018.12.017.","journal-title":"Int J Infect Dis"},{"key":"584_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90812-4","author":"KR Rijal","year":"2021","unstructured":"Rijal KR, Banjara MR, Dhungel B, et al. Use of antimicrobials and antimicrobial resistance in Nepal: a nationwide survey. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-90812-4.11,11554.","journal-title":"Sci Rep"},{"key":"584_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12941-020-00390-y","volume":"19","author":"S Manandhar","year":"2020","unstructured":"Manandhar S, Zellweger RM, Maharjan N, et al. A high prevalence of multi-drug resistant gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of extended-spectrum beta-lactamase (ESBL) and carbapenemase-encoding genes. Ann Clin Microbiol Antimicrob. 2020;19:48. https:\/\/doi.org\/10.1186\/s12941-020-00390-y.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"584_CR23","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.nmni.2021.100947","volume":"45","author":"M Sadeghi","year":"2022","unstructured":"Sadeghi M, Sedigh Ebrahim-Saraie H, Mojtahedi A. Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran. New Microbes New Infect. 2022;45:100947. https:\/\/doi.org\/10.1016\/j.nmni.2021.100947.","journal-title":"New Microbes New Infect"},{"key":"584_CR24","doi-asserted-by":"publisher","unstructured":"Onyedibe K, Shobowale E, Okolo M, Iroezindu M, Afolaranmi T, Nwaokorie F, Opajobi S, Isa S, Egah D. Low prevalence of carbapenem resistance in clinical isolates of extended spectrum beta lactamase (ESBL) producing Escherichia coli in north central, Nigeria. Advances in Infectious Diseases.2018; 8:109\u2013120. https:\/\/doi.org\/10.4236\/aid.2018.83011","DOI":"10.4236\/aid.2018.83011"},{"key":"584_CR25","doi-asserted-by":"publisher","unstructured":"Vachvanichsanong P, McNeil EB,Dissaneewate P. Extended-spectrum beta- lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections.Epidemiology and Infection.2021;149,e12,1\u20137. https:\/\/doi.org\/10.1017\/S0950268820003015","DOI":"10.1017\/S0950268820003015"},{"issue":"1","key":"584_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.18231\/2581-4761.2019.0012","volume":"5","author":"TR Chanu","year":"2019","unstructured":"Chanu TR, Shah PK, Soni S, Ghosh A. Phenotypic detection of extended spectrum, AmpC, Metallo beta-lactamases and their coexistence in clinical isolates of commonly isolated gram negative bacteria in GKGH hospital. Bhuj IP Int J Med Microbiol Trop Dis. 2019;5(1):52\u20136. https:\/\/doi.org\/10.18231\/2581-4761.2019.0012.","journal-title":"Bhuj IP Int J Med Microbiol Trop Dis"},{"issue":"1","key":"584_CR27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41598-020-79791-0","volume":"11","author":"MJ Gharavi","year":"2021","unstructured":"Gharavi MJ, Zarei J, Roshani-Asl P, Yazdanyar Z, Sharif M, Rashidi N. Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples. Sci Rep. 2021;11(1):578. https:\/\/doi.org\/10.1038\/s41598-020-79791-0.","journal-title":"Sci Rep"},{"key":"584_CR28","doi-asserted-by":"publisher","unstructured":"Kumar MS, Arunagirinathan N, Ravikumar M. Antibiotic susceptibility profile of extended spectrum \u03b2-lactamase producing Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from urinary tract infections. Research Journal of Pharmacy and Technology. 2021;14(8):4425\u20134428. https:\/\/doi.org\/10.52711\/0974-360X.2021.00768","DOI":"10.52711\/0974-360X.2021.00768"},{"issue":"8","key":"584_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1651-2227.2011.02262.x","volume":"100","author":"ZB Ozcakar","year":"2011","unstructured":"Ozcakar ZB, Yalcinkaya F, Kavaz A, Kadioglu G, Elhan AH, Aysev D, Guriz H, Ekim M. Urinary tract infections owing to ESBL-producing bacteria:microorganisms change- clinical pattern does not. Acta Paediatr. 2011;100(8):61\u20134. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02262.x.","journal-title":"Acta Paediatr"},{"issue":"4","key":"584_CR30","first-page":"645","volume":"6","author":"G Dalela","year":"2012","unstructured":"Dalela G, Gupta S, Jain DK, Mehta P. Antibiotic resistance pattern in uropathogens at a tertiary care hospital at Jhalawar with special reference to ESBL, AmpC \u03b2- lactamase and MRSA Production. J Clin D R. 2012;6(4):645\u201351.","journal-title":"J Clin D R"},{"key":"584_CR31","doi-asserted-by":"publisher","unstructured":"Nass T, Poirel L, Nordmann P. Minor extended spectrum \u03b2-lactamases.Clin MicrobiolInfect.2008;14 (Suppl.1):42\u201352. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01861.x","DOI":"10.1111\/j.1469-0691.2007.01861.x"},{"key":"584_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1574-695x.2009.00564.x","volume":"56","author":"ME Marthie","year":"2009","unstructured":"Marthie ME, Chrisna V, Eddy PM, Michael GD, Anwar AH, Marleen MK. Detection of blaSHV,blaTEM and blaCTX\u2013M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. Immunol Med Microbiol. 2009;56:191\u20136. https:\/\/doi.org\/10.1111\/j.1574-695x.2009.00564.x.","journal-title":"Immunol Med Microbiol"},{"issue":"2","key":"584_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.18869\/acadpub.mlj.11.2.30","volume":"11","author":"K Majid","year":"2017","unstructured":"Majid K, Majid B, Fateh R. Detection of TEM,SHV and CTX-M antibiotic resistance genes in Escherichia coli isolates from infected wounds. Med Lab J. 2017;11(2):30\u20135. https:\/\/doi.org\/10.18869\/acadpub.mlj.11.2.30.","journal-title":"Med Lab J"},{"key":"584_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.11604\/pamj.2020.37.213.24988","volume":"37","author":"MH Dirar","year":"2020","unstructured":"Dirar MH, Bilal NE, Ibrahim ME, Hamid ME. Prevalence of extended-spectrum \u03b2- lactamase (ESBL) and molecular detection of blaTEM, blaSHV and blaCTX\u2013M genotypes among Enterobacteriaceae isolates from patients in Khartoum. Sudan Pan Afr Med J. 2020;37:213. https:\/\/doi.org\/10.11604\/pamj.2020.37.213.24988.","journal-title":"Sudan Pan Afr Med J"},{"issue":"1","key":"584_CR35","doi-asserted-by":"publisher","first-page":"e2019041","DOI":"10.4084\/mjhid.2019.041","volume":"11","author":"P Ahmad Hamad","year":"2019","unstructured":"Ahmad Hamad P, Khadija KM. Prevalence of blaTEM, blaSHV,and blaCTX\u2013M genes among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolated from thalassemia in Erbil,Iraq. Mediterranean J Hematol Infect Dis. 2019;11(1):e2019041. https:\/\/doi.org\/10.4084\/mjhid.2019.041.","journal-title":"Mediterranean J Hematol Infect Dis"},{"key":"584_CR36","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41598-020-59772-z","volume":"10","author":"AH Noha","year":"2020","unstructured":"Noha AH, Ahmed SK, Eman MF, Adel MH, Medhat AF. Molecular characterization of extended-spectrum \u03b2 lactamase-producing E.colirecovered from community- acquired urinary tract infections in Upper Egypt. Sci Rep. 2020;10:2772. https:\/\/doi.org\/10.1038\/s41598-020-59772-z.","journal-title":"Sci Rep"},{"key":"584_CR37","doi-asserted-by":"publisher","unstructured":"Pandit R, Awal B, Shrestha SS, Joshi G, Rijal BP, Parajuli NP. Extended-spectrum \u03b2- lactamase(esbl) genotypes among multidrug-resistant uropathogenic Escherichia coli clinical isolates from a teaching hospital of Nepal. Interdisciplinary Perspectives on Infectious Diseases.2020;8. https:\/\/doi.org\/10.1155\/2020\/6525826","DOI":"10.1155\/2020\/6525826"},{"issue":"9","key":"584_CR38","first-page":"81","volume":"7","author":"NS Michael","year":"2018","unstructured":"Michael NS, Saadi AT. Detection of blaCTX\u2013M, blaTEM01 and blaSHV genes in Multidrug Resistant Uropathogenic E. coli isolated from patients with recurrent urinary tract infections. Int J Med Res Health Sci. 2018;7(9):81\u20139.","journal-title":"Int J Med Res Health Sci"},{"issue":"3","key":"584_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/jlp.jlp_31_19","volume":"11","author":"S Sahoo","year":"2019","unstructured":"Sahoo S, Otta S, Swain B, Kar SK. Detection and genetic characterization of extended- spectrum beta-lactamases producers in a tertiary care hospital. J Lab Physicians. 2019;11(3):253\u20138. https:\/\/doi.org\/10.4103\/jlp.jlp_31_19.","journal-title":"J Lab Physicians"},{"issue":"4","key":"584_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s13205-017-0879-2","volume":"7","author":"J Jena","year":"2017","unstructured":"Jena J, Sahoo RK, Debata NK, Subudhi E. Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum beta-lactamases-producing Escherichia coli strains isolated from urinary tract infections in adults. Biotech. 2017;7(4):244. https:\/\/doi.org\/10.1007\/s13205-017-0879-2.","journal-title":"Biotech"},{"key":"584_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","volume":"3","author":"R Canton","year":"2012","unstructured":"Canton R, Gonzalez-Alba JM, Galan JC. CTX-M enzymes:origin and diffusion. Front Microbiol. 2012;3:110. https:\/\/doi.org\/10.3389\/fmicb.2012.00110.","journal-title":"Front Microbiol"},{"key":"584_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1874285801913010028","volume":"13","author":"B Lohani","year":"2019","unstructured":"Lohani B, Thapa M, Sharma L, Adhikari H, Sah AK, Khanal AB, Basnet RB, Aryal M. Predominance of CTX-M type extended Spectrum \u03b2 lactamase (ESBL) producers among clinical Isolates of Enterobacteriaceae in a Tertiary Care Hospital, Kathmandu, Nepal. The OpenMicrobiology. Journal. 2019;13:28\u201333. https:\/\/doi.org\/10.2174\/1874285801913010028.","journal-title":"Journal"},{"key":"584_CR43","doi-asserted-by":"publisher","unstructured":"Parajuli NP, Maharjan P, Joshi G, Khanal PR. Emerging perils of extended spectrum \u03b2-lactamase Producing Enterobacteriaceae clinical isolates in a teaching hospital of nepal. Biomed Research International. 2016;7. https:\/\/doi.org\/10.1155\/2016\/1782835","DOI":"10.1155\/2016\/1782835"},{"issue":"4","key":"584_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/0256-4947.55306","volume":"29","author":"HM Al-Agamy","year":"2009","unstructured":"Al-Agamy HM, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae. Riyadh Saudi Arabia Annals of Saudi Medicine. 2009;29(4):253. https:\/\/doi.org\/10.4103\/0256-4947.55306.","journal-title":"Riyadh Saudi Arabia Annals of Saudi Medicine"},{"issue":"4","key":"584_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5799\/jmid.328863","volume":"6","author":"RF Polse","year":"2016","unstructured":"Polse RF, Yousif SY, Assafi MS. Prevalence and molecular characterization of extended spectrum \u03b2-lactamases producing uropathogenic Escherichia coli isolated in Zakho, Iraq. J Microbiol Infect Dis. 2016;6(4):163\u20137. https:\/\/doi.org\/10.5799\/jmid.328863.","journal-title":"J Microbiol Infect Dis"},{"issue":"1","key":"584_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/00207233.2020.1778271","volume":"78","author":"AO Adekanmbi","year":"2021","unstructured":"Adekanmbi AO, Akinpelu MO, Olaposi AV, Oyelade AA. Extended spectrum beta-lactamase encoding gene-fingerprints in multidrug resistant Escherichia coli isolated from wastewater and sludge of a hospital treatment plant in Nigeria. Int J Environ Stud. 2021;78(1):140\u201350. https:\/\/doi.org\/10.1080\/00207233.2020.1778271.","journal-title":"Int J Environ Stud"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00584-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:05:19Z","timestamp":1683281119000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00584-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00584-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Nepal Health Research Council (NHRC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent form was completed before collection of data and samples.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent form"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"33"}}